Introduction {#s1}
============

Herpesviruses are important pathogens associated with a wide range of disease in human beings and animals,and some of them are associated with cancer in their natural hosts. Epstein-Barr virus (EBV) is the etiological agent of nasopharyngeal carcinoma (NPC), African Burkitt's lymphoma, posttransplant lymphomas (PTLD), Hodgkin's disease, and some gastric cancers [@pone.0068058-Pagano1], [@pone.0068058-Damania1]. Kaposi's sarcoma-associated herpesvirus (KSHV) is linked to Kaposi sarcoma (KS) and two lymphoproliferative diseases, *i.e.* primary effusion lymphoma and multicentric Castleman's disease [@pone.0068058-Pagano1], [@pone.0068058-Damania1]. Marek's disease (MD), which is caused by Gallid herpesvirus 2 (GaHV-2), is characterized by visceral T-cell lymphomas, paralysis, blindness, and neurological dysfunction in chicken [@pone.0068058-Kaiser1]. Apart from an economically important disease affecting poultry health and welfare, MD is a good model for studying the pathogenesis and immune control of herpesvirus-induced oncogenicity [@pone.0068058-Osterrieder1], [@pone.0068058-Cheng1]. Several MDV-encoded genes related to oncogenesis have been identified, such as major oncogene *meq* (Marek's EcoR I-Q) and viral telomerase RNA [@pone.0068058-Lupiani1]. MEQ is considered to be the major viral oncoprotein of MDV and can induce transcriptional activation or repression depending on its dimerization partner and DNA binding specificity. The host response to MDV infection has been analyzed by proteomic and transcriptomic approaches. Differentially expressed proteins were mainly associated with tumor biology, protein folding, signal transduction, immunology, cell proliferation and apoptosis [@pone.0068058-Hag1]. Studying host responses to pathogens on the gene or protein level has contributed to our understanding of various host--pathogen interactions.

Microsatellite instability (MSI) is defined as a change of any length caused by either the insertion or deletion of repeating units, in a microsatellite within a tumor when compared to normal tissue [@pone.0068058-Boland1]. It has been variously reported in a range of human tumor types, including lung [@pone.0068058-SanchezCespedes1], bladder [@pone.0068058-Utting1], ovarian [@pone.0068058-Yoon1], colorectum [@pone.0068058-Boland1], and breast [@pone.0068058-Yee1] and it is the hallmark of mismatch repair (MMR) system deficiency. Loss of MMR may contribute to tumorigenesis by elevating both the rate of mutations and mitotic recombination.

The information available regarding the relationships between herpesvirus and MSI in carcinogenesis is controversial. Chang et al found that EBV-positive cases in gastric carcinomas showed no MSI positivity [@pone.0068058-Chang1], [@pone.0068058-Chang2]. However, Wu et al and Leung et al found MSI positivity in both EBV-negative and EBV-positive gastric carcinomas [@pone.0068058-Leung1], [@pone.0068058-Wu1]. In order to evaluate the involvement of GaHV-2 and MSI in Marek's disease lymphoma, forty-six microsatellite markers, which showed a high frequency of MSI in primary chicken embryo fibroblasts infected with GaHV-2 in our previous research, were selected from 304 markers to evaluate the frequency of MSI.

Materials and Methods {#s2}
=====================

Experimental Animals and Infective Virus Strain {#s2a}
-----------------------------------------------

Specific pathogen free (SPF) White Leghorn Chickens (Merial Vital Laboratory Animal Technology Co., Ltd, China) were kept at the animal isolation facility at Nannong Hi-Tech Co., Ltd (Nanjing, China). A virulent strain of MDV (GaHV-2) J-1 at passage 32, kindly provided by Merial Animal Health Co., Ltd (Shanghai, China), was used to infect the chickens.

Experimental Design {#s2b}
-------------------

After 21 days post-hatch, forty SPF White Leghorn chickens were intraabdominally inoculated with 1,000 plaque-forming units of MDV J-1 and housed in the isolation facility in separate rooms. All birds were evaluated daily for symptoms of MD, and were examined for gross MD lesions. Chickens which present ataxia or paralysis and moribund state were euthanized by CO~2~. The experiment was terminated 58 days after infection. All animal experiments were carried out in dedicated negative pressure rooms and conducted strictly in accordance with the laboratory animal guidelines. The protocol was approved by Laboratory Animal Management Committee of Jiangsu Province.

Histopathological Examination {#s2c}
-----------------------------

Tissues samples were removed and collected from chicken euthanized during the experiment period and termination, including the liver, spleen, kidney, heart, lung, peripheral nerves, skin, gonads, thymus and bursa of fabricius. Different tissue samples were fixed in 10% formalin and embedded in paraffin wax via a routine process. All sections were stained with hematoxylin and eosin (H&E) and histopathologically examined through using an optical microscope.

Detection of Microsatellite Instability {#s2d}
---------------------------------------

Microsatellite instability was detected through using gel-based nonradioactive methods described by Shang et al. [@pone.0068058-Keohavong1].

### Sample collection and genomic DNA extraction {#s2d1}

Tumor specimens that were verified visually and histopathologically were collected for MSI analysis. The genomic DNA of tumors and normal muscular tissue samples from the same chicken were extracted with TIANamp Genomic DNA kit (TIANGEN, China), according to the manufacturer's instructions. Their concentrations were determined by using a BioPhotometer plus (Eppendorf, Germany).

### Polymerase chain reaction for amplification of microsatellite markers {#s2d2}

Forty-six microsatellite markers ([Table 1](#pone-0068058-t001){ref-type="table"}), which showed a high frequency of MSI in primary chicken embryo fibroblasts infected with GaHV-2 in our previous research [@pone.0068058-Shang1], were selected from 304 markers to evaluate the frequency of MSI. PCR reaction mixtures contained the following components: 1 µl genomic DNA template (50 ng/µl), 1 µl of Taq DNA polymerase (5 U/µl), 5 µl of 10× PCR buffer, 1 µl of each primer (10 µmol/L), 4 µl of dNTPs (2.5 mmol/L), and 37 µl water. Touchdown PCR amplification was performed in a PTC-200 (Bio-Rad, USA). The initial touchdown cycle comprised denaturation at 96°C for 30 s, annealing at 65°C for 30 s, and extension at 72°C for 30 s. During the touchdown phase, the annealing temperature was decreased at the rate of 1°C for every cycle of the amplification reaction. After 10 touchdown cycles, 25 standard PCR cycles were performed under the following conditions: 96°C for 30 s, annealing at 55°C for 30 s, extension at 72°C for 30 s, and a final extension at 72°C for an additional 5 mins. The PCR reaction was terminated by adding 20 µl of gel loading dye (98% formamide, 10 mmol/L EDTA, and 0.05% bromophenol blue).

10.1371/journal.pone.0068058.t001

###### Microsatellite markers used in this study.

![](pone.0068058.t001){#pone-0068058-t001-1}

  *Marker name*    *Chromosome*       *Primer (5′-3′)*       *Size (bp)*   *Repeat array*
  --------------- -------------- -------------------------- ------------- -----------------
  MCW0248               1          GTTGTTCAAAAGAAGATGCATG     220--225         (CA) 9
                                   TTGCATTAACTGGGCACTTTC                  
  ABR0352               1           AAACCTCGGCCACGTCCATC         334           (CA) 9
                                   GGAATTAACCACCGCCACCAG                  
  ABR0329               1           TTCCCAGAGTCACTCATCTC         314           (TA) 17
                                    TTCATGGTGTATTTCTCCTG                  
  ABR0522               1           GAATTTAGGAGGCTTTGTCC         193           (CA) 9
                                    CTTTTGTGCATTTGTGGGTT                  
  MCW0145               1          ACTTTATTCTCCAAATTTGGCT        212       (CAA) 6 (CA) 20
                                   AAACACAATGGCAACGGAAAC                  
  LEI0146               1          TCAAGCCACCAAAGTGCTTGG         276           (AC)22
                                   GATCACTCTGCTCATAGCAGT                  
  ABR0204               1          TAAATAAAGGTGTTGGCAGTT         280           (CA) 20
                                  CAGATTGTTAAAATAGTTGGGTT                 
  ABR0007               1           ACACCATCCATTATGAACAC         115           (CA) 11
                                   AACAATATGACCATTAACTGC                  
  MCW0115               1          ATACCAACATCTGCCTGTGAC         252           (CA) 18
                                   GCAGTGTGTCTGACTAGCTCT                  
  ABR0004               2          CAATAGCAATGCCAAATGAAAC        99            (CA) 8
                                    GCAAGTTGATGTCCGTGGTG                  
  ABR0008               2           TAAGTGATGCGACGGGAAAG         265           (CA) 14
                                   CGCTGAGATGGAACAAAGGAG                  
  ABR0107               2           CCGTTACTGACTTCTGCTTT         250           (CA) 10
                                    TTTGTATTGGCTCCCTCATC                  
  ABR0189               2           TTAACATTAAGAGCGCATCT         109           (CA) 9
                                    ATTTGAACTTCCAAAACACT                  
  ABR0153               2           GACAGACCCACTACTGCTGA         263           (CA) 8
                                    TACCCTAACTGTTCCCACAA                  
  ABR0659               2           AAGCAACAACGTGCCTACAA         284           (CA) 12
                                   GACTATCAAGATATTCACCAAA                 
  ABR0382               4           CTTGTTGTGGAACCCTTAGT         226           (CA) 9
                                    TGAGAATCTGGCCTGATATT                  
  ABR0622               4           GAGCTCCACTCTACCCCATG         231           (CA) 15
                                    TCTTGCCAACTCCAGTCCTA                  
  ADL0266               4           AATGCATTGCAGGATGTATG      113--136         (CA) 6
                                    GTGGCATTCAGGCAGAGCAG                  
  ABR0392               5           CGAAATACAGCCCTAAGAAC         138           (CA) 9
                                    AATCCCTGTGAAGGAATCTA                  
  ABR0399               5           AGCCTAAGCATTTGAGAACA         291           (CA) 18
                                    GACAAGTCAAACCACGAAAC                  
  ABR0262               5           ATAGCAGCAGGCTCAAATGG         279           (CA) 9
                                    TTAATGGATGTAAAGGCAAA                  
  ABR0048               6         ATTCTGGGGACATCTGTGAACAC        91            (CA) 11
                                  CTGATACCTTTCAGCTGGTTGTG                 
  MCW0134               9          GGAGACTTCATTGTGTAGCAC         284           (CA) 24
                                   ACCAAAAGACTGGAGGTCAAC                  
  ABR0526               9           TCAATTCAGTACGTCCCACA         181           (CA) 10
                                    GCAGGAGCTGCCTATTACAT                  
  ABR0495               10          TTGTACTGGGTAGCATTTGA         249           (CA) 15
                                    ACTCTTTGGCCTACTTTTCC                  
  MCW0067               10         GCACTACTGTGTGCTGCAGTTT     178--184         (CA) 11
                                  GAGATGTAGTGCCACATTCCGAC                 
  ABR0325               10         CATTCTGTTTTCATTTCTGAT         156           (CA) 18
                                    ACGTGCTGCACTAATTTTAC                  
  ABR0389               11          AAAGTGCCAGACTCAACAAG         231           (CA) 12
                                   TTCCCTCTATCAGCATCCATCC                 
  ADL0308               11          CCTCTGAATGTCTGAATGAC      164--165         (CA) 13
                                    GGATGACTCCTTGGCAACAC                  
  ABR0052               11        CTGACAGAGCCTCAAAGGATAAT        209           (CA) 9
                                    TCGGCATGTGCTGACAAACA                  
  ABR0059               12        ACAAACAAGCAAGGGCCAACTAA        192           (CA) 9
                                    GCTGAGGAAGCAGCGGGTAA                  
  ABR0086               12        TGAACAGTTGTGCTGTCCAAGTT        223           (CA) 9
                                  CCCCGAAATGCTAAAAGAATGTC                 
  ABR0033               12         AAGAGGGGAGGAGGAAGCAGG         202           (CA) 10
                                   GCCTTTGCACGCATACACCAG                  
  LEI0099               12         GATCTGGCAGAACAGAAACAG         131           (CA) 12
                                   ATATTTCACACCTGACCTGCG                  
  ABR0634               12          TACTGAATAAAAGGAGGAAC         306           (CA) 21
                                    AATAGCCAAATAGGTACAGC                  
  ADL0147               13          CTGGTGAATGAGAAGCGATG      211--220         (CA) 8
                                    GCTGCGGCAATAAACTCCCT                  
  ABR0365               14         ACAGGTACAACTTTATGCAAT         222           (CA) 23
                                    AGCTAGGAAAAGAGGAAATA                  
  ABR0517               14          GCAGGATGCCTGGCAGAGGT         243           (CA) 9
                                    GGCCACCATCAGCCCCACGT                  
  ABR0387               17          AATGTGAGGTGCTGAATGGA         288           (CA) 14
                                    CTGTTGCCTGCCACAAATGG                  
  ADL0199               17          ACAAAGCCAGAGGAAACATC      154--174         (CA) 14
                                    GACGAAAGCAAGAGCAAAGC                  
  ABR0650               18          CTGAAAGAAGCAGTAAAATG         318           (CA) 11
                                    ATGGAAATGTGCCTTGGAGA                  
  ABR0133               19          CCTGGTAATGTCTGCGTTTG         199           (CA) 9
                                    GGAGCCGTTTCTGTATGTTT                  
  ABR0180               19          ATGGAATTTTACCACTGCTA         145           (CA) 11
                                    AAATGAATCAGACAGGGAAT                  
  ABR0026               20         CCGTCATCCTTCATCCGCCACA        193           (CA) 10
                                   AGCGCTGGGTGCTCCGGGTGT                  
  ABR0123               20          ACTCCAACGCCTACCAGTCA         179           (CA) 7
                                    CCATAACACCAAGCCATCAA                  
  ABR0617               26        CCAAGAACTCACATCAACGAGCAA       172           (CA) 13
                                    TGGAAGACTGGCAGGGAAGC                  

### Microsatellite instability analysis {#s2d3}

PCR products were denatured at 95°C for 5 mins with gel loading dye, and put immediately on ice for 5 mins prior to loading. About 3 µl of the PCR products were loaded onto a 12% denaturing polyacrylamide gel. The gels were run on the DCode universal mutation detection system (Bio-Rad, USA) in 1×TBE at 45°C at 180V. After electrophoresis, the gels were stained with AgNO~3~ according to the method of Sanguinetti et al [@pone.0068058-Sanguinetti1].

Results {#s3}
=======

Symptoms after Inoculation {#s3a}
--------------------------

Clinical signs of infection by GaHV-2 appeared among the treated chickens, including loss of appetite, depression, pallor, and paralysis of the wings, legs and necks. Death occurred in the second week after post-infection, and reached a peak during the 4th and 5th week. Morbidity was 75%, and mortality was 73.3% when the experiment was terminated. Pathological examination of the chickens tissues revealed that fifteen chickens (15/40, 37.5%) had significantly widespread, diffuse lymphomas involving the liver (n = 9), gonads (n = 12), spleen (n = 9), kidneys (n = 15), proventriculus (n = 6) and heart (n = 9). Tumors were found in twelve chickens after death or euthanasia and in three chickens after euthanasia at the predetermined time point. Fifteen kidney tumors were used to microsatellite instability analysis.

Microsatellite Instability Screening {#s3b}
------------------------------------

Alterations of microsatellite markers in the GaHV-2-infected samples were identified as differences in the electrophoretic migration or loss of major band(s) in comparison with normal muscular tissue samples DNA ([Fig. 1](#pone-0068058-g001){ref-type="fig"}). MSI was detected at one or more loci in all the tumors' analysis (15/15, [Table 2](#pone-0068058-t002){ref-type="table"}). Chicken no. 24 had nine loci (9/30, 30%) displaying MSI. Only one MSI locus was found in chicken nos. 5, 21, and 39.

![Denaturing polyacrylamide gel showing MSI in fifteen kidney tumors induced by GaHV-2 using six microsatellite markers.\
(A) ABR0007. (B) ABR0086. (C) ABR0352. (D) ABR0387. (E) ABR0399. (F) MCW0145. Line N, normal. Line T, tumors.](pone.0068058.g001){#pone-0068058-g001}

10.1371/journal.pone.0068058.t002

###### Number of MSI loci in different chickens.

![](pone.0068058.t002){#pone-0068058-t002-2}

  *Chicken*                               *Microsatellite markers*                                     *Chromosome*           *Number of MSI loci*
  ----------- -------------------------------------------------------------------------------- ----------------------------- ----------------------
  1                             ABR0352, ABR0522, ABR0622, ABR0086, ABR0365,                          1, 1, 4, 12, 14                 5/30
  2                                           ABR008, ABR0399                                              1, 5                       2/30
  5                                               ABR0352                                                    1                        1/30
  8                                      ABR0107, ABR0399, ABR0133                                       2, 5, 19                     3/30
  15                                          MCW0145, ABR0526                                             1, 9                       2/30
  20                             ABR0008, ABR0262, ABR0389, ABR0086 ABR0517                            2, 5,11, 12,                   5/30
  21                                              ABR0086                                                    2                        1/30
  23                            ABR0352, ABR0189, ABR0659, ADL0147, ABR0517                           1, 2, 2, 13, 14                 5/30
  24           ABR0007, ABR0352, ABR0522, MCW0145, LEI0146, ABR0052, ABR0033,ABR0634, ABR0387   1, 1, 1, 1, 1, 11, 12,12,17           9/30
  25                            MCW0145, ABR0399, ABR0389, ABR0033, LEI0099                          1, 5, 11, 12, 12                 5/30
  26                            MCW0145, ABR0659, ADL0266, ABR0086, ABR0634                           1, 2, 4, 12, 12                 5/30
  29                                 ABR0007, ABR0204, ABR0352, ABR0617                                 1, 1, 1,12                    4/30
  37                            ABR0107, ABR0387, ABR0026, ABR0123, ABR0617                          2, 17, 20, 20, 26                5/30
  38                                          ABR0204, MCW0067                                             1, 10                      2/30
  39                                              ABR0387                                                   17                        1/30

The frequency of MSI for each marker is shown in [Table 3](#pone-0068058-t003){ref-type="table"}. Microsatellite alterations exist in 30 markers among 46 microsatellite markers. In the tumor samples, the marker that showed the highest frequency of instability (5/15, 33%) was ABR0352. Microsatellite instability was displayed at ABR0086 and MCW0145 in four tumors (27%), and at ABR0007, ABR0387, and ABR0399 in three tumors (20%).

10.1371/journal.pone.0068058.t003

###### Table **3.** Frequency of MSI for each microsatellite marker.

![](pone.0068058.t003){#pone-0068058-t003-3}

  *Microsatellite markers*    *No. of Chickens*   *Frequency*   *Microsatellite markers*   *No. of Chickens*   *Frequency*
  -------------------------- ------------------- ------------- -------------------------- ------------------- -------------
  ABR0007                         2, 24, 29          3/15               ABR0389                 20, 25            2/15
  ABR0008                            20              1/15               ABR0399                2, 8, 25           3/15
  ABR0026                            37              1/15               ABR0517                 20, 23            2/15
  ABR0033                          24, 25            2/15               ABR0522                  1, 24            2/15
  ABR0052                            24              1/15               ABR0526                   15              1/15
  ABR0086                       1, 20, 21, 26        4/15               ABR0617                 29, 37            2/15
  ABR0107                           37, 8            2/15               ABR0622                    1              1/15
  ABR0123                            37              1/15               ABR0634                 24, 26            2/15
  ABR0133                             8              1/15               ABR0659                 23, 26            2/15
  ABR0189                            23              1/15               ADL0147                   23              1/15
  ABR0204                          29, 38            2/15               ADL0266                   26              1/15
  ABR0262                            20              1/15               MCW0067                   38              1/15
  ABR0352                     1, 5, 23, 24, 29       5/15               MCW0145             15, 24, 25, 26        4/15
  ABR0365                             1              1/15               LEI0099                   25              1/15
  ABR0387                        24, 37, 39          3/15               LEI0146                   24              1/15

Discussion {#s4}
==========

Since the initial description of MSI in HNPCC in 1993, MSI has been identified in a wide variety of human cancers, both familial and sporadic [@pone.0068058-Arzimanoglou1]. Microsatellite instability (MSI) is a form of genomic instability. Higher MSI frequency is a prominent genetic feature in many tumors. However, there is no study of MSI in Marek's Disease lymphoma induced by GaHV-2. In this study, we collected MD lymphoma tissue specimens, and evaluated MSI frequencies through using 46 microsatellite markers. All lymphoma showed microsatellite instability in at least one locus. These results indicated that MSI was present in Marek's disease virus-induced lymphoma. Among three serotypes, only serotype 1 MDV (GaHV-2) causes lymphoma formation in chickens, the other two serotypes (GaHV-3 and HVT) are non-pathogenic. MD vaccine strain CVI988 or HVT is effective in the prevention of tumor development but not infection. The MDV oncoprotein Meq differs between oncogenic and vaccine strains [@pone.0068058-Ajithdoss1]. It remains to be seen whether MSI frequencies is different in all kinds of MDV strains.

MSI has been thought to be closely related to mutation of proteins involved in the MMR system, which normally maintains a low rate of spontaneous mutations and corrects replication errors. Many studies noted the phenomenon of mutation of mismatch repair genes in the development and progression of human tumors [@pone.0068058-Miturski1], [@pone.0068058-Fishel1]. Lu et al had found that hypothetical protein (mismatch repair ATPase, MutS family) persistently up-regulated in the bursa of fabricius of chickens infected with the highly virulent strain [@pone.0068058-Lu1]. Interaction of MDV-encoded proteins and host cell pathways will mediate cell proliferation and apoptosis. The transcriptional regulator MEQ is considered to be the major viral oncoprotein of GaHV-2. The MEQ interacts directly with p53 and inhibits p53-mediated transcriptional activity [@pone.0068058-Deng1]. Both the MMR system and the p53 pathway are critical in the maintenance of genomic integrity [@pone.0068058-Hoffmann1], [@pone.0068058-Honma1].

A panel of five microsatellites has been validated and recommended as a reference panel for future research in the field at a National Cancer Institute Workshop meeting [@pone.0068058-Boland1]. Tumors with instability at two or more of these markers were defined as being MSI-H (high-frequency MSI), whereas those with instability at one, or showing no instability, were defined as MSI-L (low-frequency MSI) and MSS (microsatellite stable) tumors, respectively. If more than five markers are used to identify particular tumor phenotypes, then the criteria should be modified to assess the percentage of MSI rather than absolute number. The MSI-H group of tumors would be defined as having MSI in ≥30--40%, whereas the MSI-L group would exhibit MSI in \<30%. The diagnosis of MSI-H in cancers is becoming increasingly relevant; MSI-H is a useful screening marker for identifying some human tumors [@pone.0068058-Imai1]. This was the first report of MSI in Marek's Disease lymphoma, and there is no reference to MSI-H/MSI-L markers for this tumor. Therefore, we recommend six markers (ABR0007, ABR0086, ABR0352, ABR0387, ABR0399, and MCW0145) as predictive biomarkers of Marek's Disease lymphoma as 40% (6/15) demonstrated MSI-H and 93% (14/15) of lymphomas showed MSI in the present study, according to the human criteria detailed above.

In conclusion, this study demonstrates that the phenomenon of MSI does occur in Marek's disease lymphoma induced by GaHV-2. Future studies will investigate the relationships among MMR, MSI and MD tumorigenesis to better understand the molecular nature of host genomic instability and virus infection.
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